Field cancerization: Are multiple primary cancers monoclonal or polyclonal?

Annals of Medicine

Volumn 28, Issue 3, 1996, Pages 183-188

  Carey, Thomas E ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CARCINOMA; CANCER GENETICS; CAUSE OF DEATH; CHROMOSOME MARKER; EDITORIAL; EPITHELIUM; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HEAD AND NECK CANCER; HETEROZYGOSITY; HUMAN; KARYOTYPING; MULTIPLE CANCER; PRIORITY JOURNAL; SECOND CANCER; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; X CHROMOSOME;

EID: 0029898582     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899609033118     Document Type: Editorial

References (22)

1. Moore C. Cigarette smoking and cancer of the mouth, pharynx, and larynx. JAMA 1971; 218: 553-8.
2. Wynder EL, Mushinski MH, Spivak JC. Tobacco and alcohol consumption in relation to the development of multiple second primary cancers. Cancer 1977; 40: 1872-8.
3. Larson JT, Adams GL, Fattah HA. Survival statistics for multiple primaries in head and neck cancer. Otolaryngol Head Neck Surg 1990; 103: 14-24.
4. Boysen M, Loven JO. Second malignant neoplasms in patients with head and neck squamous cell carcinomas. Acta Oncologica 1993; 32: 283-8.
5. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 1990; 323: 795-801.
6. Benner SE, Pajak TF, Lippman SM, Earley C, Hong WK. Prevention of second primary tumours with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J Natl Cancer Inst 1994; 86: 140-1.
7. Slaughter DP, Southwick HW, Smejkal, W. 'Field cancerization' in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953; 6: 963-8.
8. Carey TE, Van Dyke DL, Worsham MJ, et al. Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B. Cancer Res 1989; 49: 6098-107.
9. Grenman SE, Van Dyke DL, Worsham MJ, et al. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1 A and UM-SCV-1B. Int J Cancer 1990; 45: 920-7.
10. Bradford CR, Kimmel KA, Van Dyke DL, et al. 11p deletions and breakpoints in squamous cell carcinoma: association with altered reactivity with the UM-E7 antibody. Genes Chromosom Cancer 1991; 3: 272-82.
11. Carey TE, Worsham MJ, Van Dyke DL. Chromosomal biomarkers in the clonal evolution of head and neck squamous neoplasia. J Cell Biochem Suppl 1993; 17F: 213-22.
12. Carey TE, Van Dyke DL, Worsham MJ. Nonrandom chromosome aberrations and clonal populations in head and neck cancer. Anticancer Res 1993; 13: 2561-8.
13. Van Dyke DL, Worsham MJ, Benniger MS, et al. Recurrent cytogenetic changes in squamous cell carcinomas of the head and neck region. Genes Chromosom Cancer 1994; 9: 192-206.
14. Worsham MJ, Carey TE, Benniger MS, et al. Clonal cytogenetic evolution in a squamous cell carcinoma of the skin from a xeroderma pigmentosum patient. Genes Chromosom Cancer 1993; 7: 158-64.
15. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benniger MS, Van Dyke DL. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol 1995; 26: 251-61.
16. Sidransky D, Frost P, von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B. Clonal origin of bladder cancer. N Engl J Med 1992; 326: 737-40.
17. Chung KY, Mukhopadhyay T, Jhingook K, et al. Discordant p53 mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993; 53: 1676-83.
18. Koch WM, Boyle JO, Mao L, Hakim J, Hruban RH, Sidransky D. p53 gene mutations as markers of tumor spread in synchronous oral cancers. Arch Otolaryngol Head Neck Surg 1994; 120: 943-7.
19. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with tumor progression of head and neck cancer. Cancer Res 1993; 53: 4477-80.
20. El-Naggar AK, Lai S, Zhou X-D, et al. Sequential p53 mutation analysis of preinvasive head and neck squamous carcinoma. Int J Cancer 1995; 64: 196-201.
21. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989; 17: 449-56.
22. Vikram B. Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 1984; 110: 564-5.